凯思凯迪

Enterprise Software/SaaS

Kaiskadi is a biopharmaceutical R&D company focused on innovative therapeutics, including novel nucleic acid drugs and drugs targeting new mechanisms and biological targets. Its R&D team includes scientists from GlaxoSmithKline, Baylor College of Medicine, the Van Andel Institute, the Chinese…

Latest round: Series B (2025)